Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 78

Sort by

Sort Order Select

Journal Articles

Fecal microbiota diversity disruption and clinical outcomes after auto-HCT: a multicenter observational study

Blood (2021) 137 (11): 1527–1537.

https://doi.org/10.1182/blood.2020006923

Published: 2021

Includes: Supplemental data

Journal Articles

Analysis of Intestinal Microbiome in Multiple Myeloma Reveals Progressive Dysbiosis Compared to MGUS and Healthy Individuals

Crystal Antoine Pepeljugoski, MD, Gareth Morgan, MD PhD, Marc Braunstein, MD PhD

Blood (2019) 134 (Supplement_1): 3076.

https://doi.org/10.1182/blood-2019-130643

Published: 2019

Journal Articles

Effects of Rifaximin on Intestinal Pathophysiologic Changes Associated with Sickle Cell Disease (SCD)

Dibyendu Dutta, PhD, Seah H Lim, MD PhD

Blood (2019) 134 (Supplement_1): 2282.

https://doi.org/10.1182/blood-2019-127043

Published: 2019

Journal Articles

Alterations of Gut Microbiome Accelerate Multiple Myeloma Progression By Increasing the Relative Abundances of Nitrogen Recycling Bacteria

Xingxing Jian, PhD, Yinghong Zhu, Jian Ouyang, Qian Lei, Jiliang Xia, PhD, Jingyu Zhang, Jiaojiao Guo, Jinuo Wang, MD, Jingchao Lin, Mingming Su, Yongjun Guan, Guancheng Li, PhD, Minghua Wu, PhD, Jian Li, MD, Juanjuan Xiang, PhD, Lu Xie, PhD, Lugui Qiu, MD PhD, Wei Jia, PhD, Wen Zhou, PhD

Blood (2019) 134 (Supplement_1): 688.

https://doi.org/10.1182/blood-2019-125051

Published: 2019

Journal Articles

Antibiotic Exposures and Dietary Intakes Are Associated with Changes in Microbiota Compositions in Allogeneic Hematopoietic Stem Cell Transplant Patients

Chi L. Nguyen, BA, Antonio L.C. Gomes, PhD, Jonathan U. Peled, MD PhD, John B. Slingerland, BSc, Ann E. Slingerland, BSc, Marissa L. Buchan, MS, Peter A. Adintori, MS, RD, CDN, Kate A Markey, PhDMBBS,FRACP, Annelie Clurman, BA, Molly A. Maloy, MS, Sergio A. Giralt, MD, Miguel-Angel Perales, MD, Ying Taur, MD MPH, Xavier B. Joao, PhD, Eric G. Pamer, MD, Marcel R.M. van den Brink, MD PhD

Blood (2019) 134 (Supplement_1): 597.

https://doi.org/10.1182/blood-2019-130578

Published: 2019

Journal Articles

Impact of Gut Mycobiota Composition on Outcomes after Allogeneic Hematopoietic Cell Transplantation

Florent Malard, MD PhD, Giorgia Battipaglia, MD, Béatrice Gaugler, PhD, Rémy Duléry, MD, Eolia Brissot, MD PhD, Tounes Ledraa, MD, Razan Mohty, MD, Harry Sokol, MD PhD, Mohamad Mohty, MD PhD

Blood (2019) 134 (Supplement_1): 194.

https://doi.org/10.1182/blood-2019-122256

Published: 2019

Journal Articles

Pilot Study of Telmisartan (Micardis) for Prevention of Acute Graft Vs. Host Disease after Allogeneic Hematopoietic Stem Cell Transplantation: Interim Analysis

Sujatha Iyengar, PhD, Scott D. Rowley, MD, Caixin Zhan, Michele L. Donato, MD, Themba Nyirenda, PhD, David H. Schwartz, MD PhD

Blood (2019) 134 (Supplement_1): 4546.

https://doi.org/10.1182/blood-2019-129378

Published: 2019

Journal Articles

Autologous Transplant Recipients Have a Healthier Gut Microbiota at Baseline and Faster Recovery from Microbiome Injury Compared to Allogeneic Transplant Recipients

Rajat Bansal, MD, Heekuk Park, Cristian Taborda, Christian Gordillo, BS, Markus Y. Mapara, MD PhD, Amer Assal, MD, Anne-Catrin Uhlemann, MD, Ran Reshef, MDMSc

Blood (2019) 134 (Supplement_1): 4491.

https://doi.org/10.1182/blood-2019-129304

Published: 2019

Journal Articles

Sparing of the Lower Gastrointestinal Tract Microbiota Is Associated with Reduced Acute Graft-Versus-Host Disease

Doris M Ponce, MD, Marina D Burgos da Silva, PhD, Antonio L.C. Gomes, PhD, Gillian Moore, BA, John B. Slingerland, BSc, Eric G. Pamer, MD, Ying Taur, MD MPH, Jonathan U. Peled, MD PhD, Marcel R.M. van den Brink, MD PhD

Blood (2019) 134 (Supplement_1): 4538.

https://doi.org/10.1182/blood-2019-131067

Published: 2019

Journal Articles

The Blood Microbiome Predicts Acute Graft-Versus-Host Disease after Stem Cell Transplantation

Lily Blair, PhD, Jonathan U. Peled, MD, Paul A Giardina, John B. Slingerland, BSc, Ann E. Slingerland, BSc, Desiree Hollemon, MPH, MSN, Carine Ho, Sivan Bercovici, Asim Ahmed, David K Hong, MD, Sergio A. Giralt, MD, Ying Taur, MD MPH, Marcel R.M. van den Brink, MD PhD, Kate A Markey, PhDMBBS,FRACP

Blood (2019) 134 (Supplement_1): 4513.

https://doi.org/10.1182/blood-2019-129272

Published: 2019

Journal Articles

Alterations of Gut Microbiome in Untreated Chronic Lymphocytic Leukemia (CLL); Future Therapeutic Potentials

Mohammed Kawari, Mahmood Akhtar, Mohamed Sager, Zakaria Basbous, Ibrahim Baydoun, Juma Kabanja, Mohammed Darweesh, MD, Nihad Mokhtar, MD, Solaf Kanfar, MD, Enas Mutahar, MD, John Apostolidis, MD, Khalid Ahmed Al-Anazi, MD, Hani Al Hashmi, MD

Blood (2019) 134 (Supplement_1): 5455.

https://doi.org/10.1182/blood-2019-121643

Published: 2019

Journal Articles

Longitudinal Changes in the Intestinal Microbiome Composition Following Gut Decontamination in Pediatric Allogeneic Hematopoietic Stem Cell Transplant Patients: A Pilot Study

Christopher Severyn, MD PhD, Wendy B. London, PhD, Paige Kao, MPH, Sophie Silverstein, BS, Michelle Li, BS, Soomin Kim, BA, Kelly Verrill, BSN, Jerome Ritz, MD, Ami S. Bhatt, MD PhD, Jennifer Whangbo, MD PhD

Blood (2019) 134 (Supplement_1): 5665.

https://doi.org/10.1182/blood-2019-122480

Published: 2019

Journal Articles

Cpit (Check Point Inhibitor Trial) 002: Phase I Study of Single-Agent and Combined Checkpoint Inhibition (CI) after Allogenic Hematopoietic Stem Cell Transplantation (alloHCT) in Patients at High Risk for Post-Transplant Recurrence

Jamie Koprivnikar, MD, James K McCloskey, MD, Rena Feinman, PhD, Robert Korngold, PhD, Michele L. Donato, MD, Scott D. Rowley, MD, Themba Nyirenda, PhD, Andrew L. Pecora, MD

Blood (2019) 134 (Supplement_1): 5618.

https://doi.org/10.1182/blood-2019-132025

Published: 2019

Journal Articles

The Nutrient Trial (NUTRitional Intervention among myEloproliferative Neoplasms): Feasibility Phase

Laura F. Mendez, Hellen Nguyen, Jenny Nguyen, Alexander Himstead, Melinda R. Lemm, Elena S. Heide, Robyn M. Scherber, MDMPH, Aditi Choudhry, MD, Chelsea O. McKinney, Ruben A. Mesa, MD, Lari Wenzel, Andrew Odegaard, Angela G. Fleischman, MD PhD

Blood (2019) 134 (Supplement_1): 5380.

https://doi.org/10.1182/blood-2019-130851

Published: 2019

Journal Articles

Financial Incentives to Increase Stool Collection Rates for Microbiome Studies in Adult Bone Marrow Transplant Patients

Jillian C. Thompson, MS, Yi Ren, MS, Kristi M. Romero, BS, Meagan V. Lew, BS, Amy T. Bush, BS, Julia A. Messina, MD, Sin-Ho Jung, PhD, Julie M. Miller, PhD, Zachary Zenko, PhD, Robert R. Jenq, MD, Jonathan U. Peled, MD, Marcel R.M. van den Brink, MD PhD, Nelson J. Chao, MD, Anthony D. Sung, MD

Blood (2019) 134 (Supplement_1): 5775.

https://doi.org/10.1182/blood-2019-128702

Published: 2019

Journal Articles

Rational Modification of Intestinal Microbiome and Metabolites after Allogeneic Hematopoietic Stem Cell Transplantation with Resistant Starch: A Pilot Study

Mary Mansour Riwes, DO, Alexander Schmidt, Thomas Braun, John M. Magenau, MD, Attaphol Pawarode, Brian Parkin, Sarah Anand, MD, Monalisa Ghosh, John Maciejewski, Darren King, Muneesh Tewari, Sung W. Choi, Gregory A. Yanik, Kristi Maccready, Thomas Schmidt, Pavan Reddy

Blood (2019) 134 (Supplement_1): 3276.

https://doi.org/10.1182/blood-2019-131216

Published: 2019

Journal Articles

Serum Citrulline As a Biomarker for Blood Stream Infections in Pediatric Hematopoietic Stem Cell Transplant Patients

Shyamli Singla, MD, Justin Wong, Shuang Jiang, Sarah Hussain, Laura Coughlin, Xiaowei Zhan, PhD, Andrew Y. Koh, MD

Blood (2019) 134 (Supplement_1): 3268.

https://doi.org/10.1182/blood-2019-127061

Published: 2019

Journal Articles

Changes in Gut Microbial Diversity and Correlations with Clinical Outcomes in Patients with Newly Diagnosed Acute Myeloid Leukemia (AML) Receiving Intensive Chemotherapy

Sangmin Lee, MD, Ellen K. Ritchie, MD, Sumaiya Miah, Caroline Andy, Tania Curcio, Finola Goudy, Michael Hovan, Claire Douglass, Pinkal Desai, MDMPH, Michael B. Samuel, MD, Gail J. Roboz, MD, Michael Satlin, MD, M.S.

Blood (2019) 134 (Supplement_1): 1336.

https://doi.org/10.1182/blood-2019-125441

Published: 2019

Journal Articles

Impact of Antibiotics on Gut Microbiota Diversity and the Results of a Prospective Dietary Assessment in Patients with Multiple Myeloma Undergoing Autologous Hematopoietic Stem Cell Transplantation

Christopher D'Angelo, MD, Sailendharan Sudakaran, PhD, Peiman Hematti, MD, Fotis Asimakopoulos, PhDMBBChir,, Craig Augustine, MBA, Nasia Safdar, MD PhD, Natalie Scott Callander, MD

Blood (2019) 134 (Supplement_1): 4653.

https://doi.org/10.1182/blood-2019-123530

Published: 2019

Journal Articles

Pre-Transplant Fecal Microbial Diversity Independently Predicts Critical Illness after Hematopoietic Cell Transplantation

Blood (2019) 134 (Supplement_1): 3264.

https://doi.org/10.1182/blood-2019-124902

Published: 2019

NARROW

Fecal microbiota diversity disruption and clinical outcomes after auto-HCT: a multicenter observational study

Analysis of Intestinal Microbiome in Multiple Myeloma Reveals Progressive Dysbiosis Compared to MGUS and Healthy Individuals

Effects of Rifaximin on Intestinal Pathophysiologic Changes Associated with Sickle Cell Disease (SCD)

Alterations of Gut Microbiome Accelerate Multiple Myeloma Progression By Increasing the Relative Abundances of Nitrogen Recycling Bacteria

Antibiotic Exposures and Dietary Intakes Are Associated with Changes in Microbiota Compositions in Allogeneic Hematopoietic Stem Cell Transplant Patients

Impact of Gut Mycobiota Composition on Outcomes after Allogeneic Hematopoietic Cell Transplantation

Pilot Study of Telmisartan (Micardis) for Prevention of Acute Graft Vs. Host Disease after Allogeneic Hematopoietic Stem Cell Transplantation: Interim Analysis

Autologous Transplant Recipients Have a Healthier Gut Microbiota at Baseline and Faster Recovery from Microbiome Injury Compared to Allogeneic Transplant Recipients

Sparing of the Lower Gastrointestinal Tract Microbiota Is Associated with Reduced Acute Graft-Versus-Host Disease

The Blood Microbiome Predicts Acute Graft-Versus-Host Disease after Stem Cell Transplantation

Alterations of Gut Microbiome in Untreated Chronic Lymphocytic Leukemia (CLL); Future Therapeutic Potentials

Longitudinal Changes in the Intestinal Microbiome Composition Following Gut Decontamination in Pediatric Allogeneic Hematopoietic Stem Cell Transplant Patients: A Pilot Study

Cpit (Check Point Inhibitor Trial) 002: Phase I Study of Single-Agent and Combined Checkpoint Inhibition (CI) after Allogenic Hematopoietic Stem Cell Transplantation (alloHCT) in Patients at High Risk for Post-Transplant Recurrence

The Nutrient Trial (NUTRitional Intervention among myEloproliferative Neoplasms): Feasibility Phase

Financial Incentives to Increase Stool Collection Rates for Microbiome Studies in Adult Bone Marrow Transplant Patients

Rational Modification of Intestinal Microbiome and Metabolites after Allogeneic Hematopoietic Stem Cell Transplantation with Resistant Starch: A Pilot Study

Serum Citrulline As a Biomarker for Blood Stream Infections in Pediatric Hematopoietic Stem Cell Transplant Patients

Changes in Gut Microbial Diversity and Correlations with Clinical Outcomes in Patients with Newly Diagnosed Acute Myeloid Leukemia (AML) Receiving Intensive Chemotherapy

Impact of Antibiotics on Gut Microbiota Diversity and the Results of a Prospective Dietary Assessment in Patients with Multiple Myeloma Undergoing Autologous Hematopoietic Stem Cell Transplantation

Pre-Transplant Fecal Microbial Diversity Independently Predicts Critical Illness after Hematopoietic Cell Transplantation

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only